Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?
University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...
Bariatric surgeries entail a layered verification process that delays approvals but things are moving as surgeries go up.
Abalone Bio, an antibody company measuring large-scale activity data to drive AI-powered discovery of active therapeutics, ...
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
At a recent news conference, Lei Haichao, head of the National Health Commission (NHC), announced plans to establish more ...
A National Institutes of Health study aims to find out whether ultraprocessed foods lead people to eat more. And, if so, why?
Pancreatic cancer, one of the deadliest types of the disease, has been linked to obesity and higher stress levels, a new UCLA study found. Doctors share how to reduce the risk.
Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results